| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 25, 2002
Accepted on July 17, 2002
From the Center for Thrombosis and Hemostasis (D.M.M., H.R.R.), University of North Carolina, Chapel Hill, and the Department of Pathology (M.H.), Duke University, Durham, NC.
* To whom correspondence should be addressed. E-mail: dmonroe{at}med.unc.edu.
AbstractThis review examines the evidence that platelets play a major role in localizing and controlling the burst of thrombin generation leading to fibrin clot formation. From the first functional description of platelets, it has been recognized that platelets supply factors that support the activation of prothrombin. Studies have demonstrated that on activation, the amount of one specific lipid, phosphatidylserine, is significantly increased on the outer leaflet of platelet membranes. When it was found that phosphatidylserine containing lipid extracts could be substituted for platelets in clotting assays, this suggested the possibility that changes in platelet lipid composition were necessary and sufficient to account for platelet surface thrombin generation. Because a growing body of data suggest that platelet-binding proteins provide much of the specificity for platelet thrombin generation, we review in this report data suggesting that changes in lipid composition are necessary but not sufficient to account for platelet surface regulation of thrombin generation, Also, we review data suggesting that platelets from different individuals differ in their capacity to generate thrombin, whereas platelets from a single subject support thrombin generation in a reproducible manner. Individual differences in platelet thrombin generation might be accounted for by differences in platelet-binding proteins.
This article has been cited by other articles:
![]() |
M. C. Grant, Z. Kon, A. Joshi, E. Christenson, S. Kallam, N. Burris, J. Gu, and R. S. Poston Is Aprotinin Safe to Use in a Cohort at Increased Risk for Thrombotic Events: Results From a Randomized, Prospective Trial in Off-Pump Coronary Artery Bypass Ann. Thorac. Surg., September 1, 2008; 86(3): 815 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Touat, L. Lepage, V. Ollivier, P. Nataf, U. Hvass, J. Labreuche, M. Jandrot-Perrus, J.-B. Michel, and G. Jondeau Dilation-Dependent Activation of Platelets and Prothrombin in Human Thoracic Ascending Aortic Aneurysm Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 940 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Q. Monteiro, A. R. Rezaie, J.-S. Bae, E. Calvo, J. F. Andersen, and I. M.B. Francischetti Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite Protein Sci., January 1, 2008; 17(1): 146 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, W. Beck, R. Deppisch, S. M. Marshall, N. A. Hoenich, and M. G. Thompson Differential effects of dialysis and ultrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization Am J Physiol Renal Physiol, January 1, 2008; 294(1): F220 - F228. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C.A. Munnix, M. J.E. Kuijpers, J. Auger, C. M.L.G.D. Thomassen, P. Panizzi, M. A.M. van Zandvoort, J. Rosing, P. E. Bock, S. P. Watson, and J. W.M. Heemskerk Segregation of Platelet Aggregatory and Procoagulant Microdomains in Thrombus Formation: Regulation by Transient Integrin Activation Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2484 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Schneider and B. E. Sobel Conundrums in the Combined Use of Anticoagulants and Antiplatelet Drugs Circulation, July 17, 2007; 116(3): 305 - 315. [Full Text] [PDF] |
||||
![]() |
Y. Wang, W. Beck, R. Deppisch, S. M. Marshall, N. A. Hoenich, and M. G. Thompson Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors Am J Physiol Cell Physiol, July 1, 2007; 293(1): C328 - C336. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Panes, V. Matus, C. G. Saez, T. Quiroga, J. Pereira, and D. Mezzano Human platelets synthesize and express functional tissue factor Blood, June 15, 2007; 109(12): 5242 - 5250. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stoll, N. Bassler, C. E. Hagemeyer, S. U. Eisenhardt, Y. C. Chen, R. Schmidt, M. Schwarz, I. Ahrens, Y. Katagiri, B. Pannen, et al. Targeting Ligand-Induced Binding Sites on GPIIb/IIIa via Single-Chain Antibody Allows Effective Anticoagulation Without Bleeding Time Prolongation Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1206 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Caterina, S. Husted, L. Wallentin, G. Agnelli, F. Bachmann, C. Baigent, J. Jespersen, S. D. Kristensen, G. Montalescot, A. Siegbahn, et al. Anticoagulants in heart disease: current status and perspectives Eur. Heart J., April 10, 2007; (2007) ehl492v1. [Full Text] [PDF] |
||||
![]() |
E. L. Howard, K. C.D. Becker, C. P. Rusconi, and R. C. Becker Factor IXa Inhibitors as Novel Anticoagulants Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 722 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Touat, V. Ollivier, J. Dai, M.-G. Huisse, A. Bezeaud, U. Sebbag, T. Palombi, P. Rossignol, O. Meilhac, M.-C. Guillin, et al. Renewal of Mural Thrombus Releases Plasma Markers and Is Involved in Aortic Abdominal Aneurysm Evolution Am. J. Pathol., March 1, 2006; 168(3): 1022 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C.A. Munnix, A. Strehl, M. J.E. Kuijpers, J. M. Auger, P. E.J. van der Meijden, M. A.M. van Zandvoort, M. G.A. oude Egbrink, B. Nieswandt, and J. W.M. Heemskerk The Glycoprotein VI-Phospholipase C{gamma}2 Signaling Pathway Controls Thrombus Formation Induced by Collagen and Tissue Factor In Vitro and In Vivo Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2673 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. MacCallum Markers of Hemostasis and Systemic Inflammation in Heart Disease and Atherosclerosis in Smokers Proceedings of the ATS, April 1, 2005; 2(1): 34 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Kempton, M. Hoffman, H. R. Roberts, and D. M. Monroe Platelet Heterogeneity: Variation in Coagulation Complexes on Platelet Subpopulations Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Burdick and K. Konstantopoulos Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow Am J Physiol Cell Physiol, August 1, 2004; 287(2): C539 - C547. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Torsney, U. Mayr, Y. Zou, W. D. Thompson, Y. Hu, and Q. Xu Thrombosis and Neointima Formation in Vein Grafts Are Inhibited by Locally Applied Aspirin Through Endothelial Protection Circ. Res., June 11, 2004; 94(11): 1466 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M W H Behan and R F Storey Antiplatelet therapy in cardiovascular disease Postgrad. Med. J., March 1, 2004; 80(941): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.A. Stouffer and S.S. Smyth Effects of Thrombin on Interactions Between {beta}3-Integrins and Extracellular Matrix in Platelets and Vascular Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1971 - 1978. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leon, C. Ravanat, M. Freund, J.-P. Cazenave, and C. Gachet Differential Involvement of the P2Y1 and P2Y12 Receptors in Platelet Procoagulant Activity Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1941 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Dumas, R. Kumar, J. Seehra, W. S. Somers, and L. Mosyak Crystal Structure of the GpIb{alpha}-Thrombin Complex Essential for Platelet Aggregation Science, July 11, 2003; 301(5630): 222 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Goel and Scott. L. Diamond Neutrophil Cathepsin G Promotes Prothrombinase and Fibrin Formation under Flow Conditions by Activating Fibrinogen-adherent Platelets J. Biol. Chem., March 7, 2003; 278(11): 9458 - 9463. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Monroe and H. R. Roberts Mechanism of Action of High-Dose Factor VIIa: Points of Agreement and Disagreement Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 8 - 9. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |